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Background. GPs apply several treatments for patients with cutaneous warts. Available evidence
recommends salicylic acid application.
Objective. We investigated whether current choices of GPs in the treatment of warts are in agree-
ment with available evidence.
Methods. A nationwide random sample of 700 Dutch GPs received a postal questionnaire on
their choices in the treatment of warts. In addition, factors that influence these choices, their view
on the effectiveness of treatments and their view on the natural history of warts were assessed.
Results. The questionnaire was returned by 280 GPs (40%). Cryotherapy was first choice treat-
ment in 73% of GPs for hand warts, 49% of GPs for plantar warts and 72% of GPs for warts on
other locations. Salicylic acid application or the combination of cryotherapy and salicylic acid
were used less frequently, followed by an expectant awaiting policy and (electro) surgery.
Most important factors influencing their treatment choice were GPs’ routine and GPs’ views
on effectiveness.
Conclusions. In contrast to available evidence, most GPs apply cryotherapy as first choice treat-
ment of cutaneous warts. Pragmatic high-quality trials on the effectiveness of wart treatments
conducted in primary care might solve this discrepancy between evidence and practice.
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Introduction
Up to one-third of primary school children have cuta-
neous warts.1 The prevalence of warts presented to
GPs over a year is 2% in general population and adds
up to 6% in school children.2,3 Warts rank 11th in most
frequently presented complaints and diseases in general
practice.2,3 However, subsequent wart treatment causes
annoying side effects and often is as effective as expec-
tantly awaiting. As a consequence, different treatment
modalities are applied.4
Previous studies carried out nearly two decades ago
showed that in general practice, if available, liquid ni-
trogen cryotherapy was most frequently applied. When
cryotherapy was not available, topical salicylic acid
was prescribed or patients were referred to dermatol-
ogy clinics.5,6 However, after these studies were con-
ducted, wart management has changed considerably.
Firstly, availability of liquid nitrogen has increased ex-
tensively and many general practices now have wart
clinics in which cryotherapy is implemented. Secondly,
the recent Cochrane review on topical treatments for
warts concludes that, although evidence is sparse and
conflicting, salicylic acid is the most effective treatment
option.7 As a result, present guidelines recommend sal-
icylic acid as first choice treatment of warts.8,9
We performed a survey on choices in the treatment
of warts among GPs in the Netherlands in order to in-
vestigate whether current practice is in agreement
with current evidence. We also explored GPs’ views
on effectiveness of treatment and natural history of
warts in order to explicate their treatment choices.
Methods
Preparation
In April 2006, we enrolled GPs with different back-
grounds for explorative semi-structured individual in-
terviews on wart management. The interviews were
moderated by two researchers. Field notes were dis-
cussed by all authors and translated into hypotheses.
Sufficient information for this process was gathered












experience ranging from 8 to 20 years, working in
single-handed duo or group practice). Based on the re-
sults from these interviews, we constructed the postal
questionnaire.
In June 2006, the postal questionnaire was sent to a
random sample of 700 GPs from the GP register of the
Netherlands Institute for Health Services Research.10
Three weeks after initial mailing, GPs who had not
returned the questionnaire received a reminder.
Questionnaire
We clearly defined that all questions concerned
patients with cutaneous warts, i.e. common warts or
plantar warts, excluding genital warts or mollusca con-
tagiosa. We asked GPs to estimate the percentages of
patients treated with each of the various treatments in
their practice (adding up to 100% in total), separately
for patients with hand warts, plantar warts and other
warts (warts on parts of the skin other than hands or
feet). GPs could choose from the following treatments:
cryotherapy, salicylic acid, combination of cryotherapy
and salicylic acid, an expectantly awaiting policy, (elec-
tro) surgical removal or another specific treatment.4
We assessed factors, which influence GPs in these
treatment choices, i.e. routine, scientific evidence, finan-
cial considerations, the balance between effectiveness
and side effects, colleagues’ opinions and practical/or-
ganizational considerations. In addition, we assessed
the views on effectiveness of different treatments and
their views on the natural history of warts. We graded
these opinions using statements in the questionnaire ac-
cording to 5-point rating scales. These answers were
later dichotomized into ‘effective’ (‘very effective’ and
‘effective’ combined) and ‘not effective’ (‘absolutely
not effective’, ‘not effective’ and ‘moderately effective’
combined) for GPs’ views on effectiveness of different
treatments and into ‘agree’ (‘agree’ and ‘strongly agree’
combined) and ‘not agree’ (‘do not agree or disagree’,
‘disagree’ and ‘strongly disagree’ combined) for GPs’
views on the natural history of warts because five cate-
gories did not reveal additional information over two
categories.
Statistical analysis
We compared main characteristics of participating
GPs with main characteristics of all Dutch GPs.10 Re-
sults are displayed as percentages with corresponding
95% confidence intervals (CI). We used chi-square
tests to compare categorical data. Data were analysed
with SPSS Version 16.0 and Episheet, Version 2003.11
Results
GPs’ response rate was 40% (280/700). Participating
GPs covered a practice population of 550 000 citi-
zens and were representative for the Dutch population
of GPs (Table 1). In total, only 9% (95% CI 6%–
13%) of GPs did not have liquid nitrogen available
and 20% (95% CI 16%–26%) did not use salicylic acid
(Table 2). GPs estimated that 5% of their patients
with warts were referred to dermatologic or surgical
outpatient clinics.
Cryotherapy was most often used as GPs’ first
choice treatment for all warts, followed by salicylic
acid application and cryotherapy/salicylic acid combi-
nation therapy (Table 3). Treatments with salicylic
acid were more frequently applied in plantar warts
compared to hand warts or other warts. For all warts,
only 5%–7% of GPs used an expectantly awaiting pol-
icy as first choice and only few GPs used monochloro-
acetic acid12 or duct tape13 as first choice treatment.
In other warts, 26 GPs (10%) used (electro) surgery
as first choice.
Several factors influenced GPs’ treatment choice: of
all GPs (n = 280, missing data in n = 8 to n = 23 per
factor), 59% (95% CI 53%–65%) was influenced by
routine, 46% (95% CI 40%–52%) by the balance be-
tween effectiveness and side effects, 29% (95% CI






Male 60 (54–66) 66 (65–67)
Mean age in years (SD) 46.6 (8.7) 47.9 (8.3)
GP in urban practice 86 (82–90) 88 (87–88)
GP working in
Single-handed practice 31 (26–36) 25 (24–26)
Duo practice 30 (25–35) 30 (29–31)
Group practice 40 (34–45) 45 (44–46)
Data are percentage of GPs (95% confidence intervals), unless stated
otherwise.
TABLE 2 Aspects of wart management in general practice (n = 280)
Assistant regularly provides
Oral information 82 (77–86)
Written information 17 (12–22)




Salicylic acid prescription used
Solution 31%–50% 23 (18–28)
Solution <30% 57 (51–62)
No 20 (16–26)
Mean percentage (SD) of treatments applied by
Practice assistant 68 (36)
GP 32 (34)
Numbers are percentage of GPs (95% confidence intervals), unless
stated otherwise. Data are missing for 52 GPs in information data,
none in nitrogen availability data, 5 GPs in salicylic acid use and 1
GP in implementation data.
aSum of percentages is not equal to 100% due to rounding off.
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24%–35%) by evidence, 25% (95% CI 20%–30%) by
colleagues’ opinions, 21% (95% CI 17%–27%) by
practical/organizational considerations and 5% (95%
CI 3%–8%) by financial motives. Of all GP’s, 71%
(95% CI 65%–76%) considered cryotherapy to be ef-
fective versus 55% (95% CI 49%–61%) for salicylic
acid, 66% (95% CI 60%–71%) for the combination
therapy and 47% (95% CI 41%–53%) for an ex-
pectantly awaiting policy (Table 4). The GPs using
cryotherapy as first choice treatment more often con-
sidered cryotherapy to be effective than GPs not using
cryotherapy as first choice treatment (P < 0.001).
According to 82% (95% CI 77%–86%) of GPs,
warts are self-limiting and according to 34% (95% CI
29%–40%) of GPs, warts are very contagious. The
percentages of GPs agreeing with these two state-
ments did not differ between the GPs with an expect-
ing awaiting policy as their first choice and GPs with
active treatments as their first choice (P = 0.83 and
P = 0.20, respectively) and did also not differ between
the GPs who considered an expectantly awaiting
policy to be effective and those who considered an ex-
pectantly awaiting policy not to be effective (P =
0.076 and P = 0.26, respectively). A majority of all
GPs [73% (95% CI 68%–78%)] reported to advise
patients with warts to expectantly wait when the
inconvenience caused by warts is limited.
Discussion
Summary of main findings
Cryotherapy is the first choice treatment of warts
among Dutch GPs. Salicylic acid is used less fre-
quently and often in combination with cryotherapy.
GPs’ treatment choices are guided by their routine
and their views on effectiveness rather than evidence
or opinions on the natural history. Although GPs most
often choose active treatments, they prefer an expec-
tantly awaiting policy when inconvenience caused by
warts is limited because they believe warts are self-
limiting.
TABLE 3 GPs’ first choice treatment of warts depending on location (n = 280)
Location of warts
Hand (n = 278) Plantar (n = 276) Other locations (n = 266)
First choice treatment n % (95% CI) n % (95% CI) n % (95% CI)
Cryotherapy 204 73 (68–78) 136 49 (43–55) 192 72 (67–77)
Combination of cryotherapy
and salicylic acid
45 16 (12–21) 82 30 (25–35) 23 9 (6–13)
Salicylic acid 30 11 (8–15) 50 18 (14–23) 32 12 (9–16)
Expectantly awaiting 19 7 (4–10) 15 5 (3–9) 22 8 (6–12)
(Electro)surgery 4 1 (1–4) 8 3 (1–6) 26 10 (7–14)
Monochloroacetic acid 8 3 (1–6) 10 4 (2–7) 5 2 (1–4)
Duct tape 0 0 (0–1) 3 1 (0–3) 2 1 (0–3)
Data are numbers of GPs and percentage of GPs (95% confidence intervals). Data are missing for 2 GPs in hand, 4 GPs in plantar and 14 GPs in
other warts. Sum of GPs is >280 and sum of percentages is >100% per location of warts because 10%–14% of GPs reported to apply two or three
different treatments equally frequent.
TABLE 4 Perceived effectiveness of different treatments according to GPs’ personal experience (n = 280)
Treatment
GPs personal experience
Effective Not effective No experience with treatment
Cryotherapya 71 (65–76) 27 (22–32) 3 (1–5)
Combination of cryotherapy
and salicylic acid
66 (60–71) 15 (11–20) 19 (15–24)
Salicylic acid 55 (49–61) 39 (33–45) 6 (4–10)
Surgical removal 42 (36–48) 37 (31–43) 21 (16–26)
Monochloroacetic acid 25 (20–31) 23 (18–28) 52 (46–58)
Duct tape 12 (9–16) 26 (21–32) 62 (56–67)
Homeopathy 3 (1–5) 59 (53–65) 38 (33–44)
Expectantly awaitinga 47 (41–53) 45 (39–51) 9 (6–13)
Numbers are percentage of GPs (95% confidence intervals). Data are missing for 1–15 GPs per treatment.
aSum of percentages is not equal to 100% due to rounding off.
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Strengths and limitations of this study
This is the first quantitative study on choices in the
treatment of warts after cryotherapy became widely
available in primary care and after the Cochrane review
on topical treatments of warts has been published.7 Our
sample of GPs was large and representative for all
Dutch GPs. Moreover, we think that our results contain
patterns that are likely to be similar in other countries
in which patients with warts are primarily treated in
general practice and liquid nitrogen is widely available.
A limitation of our study is the response rate of
40%. Although our response rate is comparable to re-
sponse rates of surveys among GPs in literature,14 and
our responders in general did not differ from all Dutch
GPs, the high preference for cryotherapy might be due
to some selection bias. Perhaps, GPs interested in wart
treatment and cryotherapy have responded more of-
ten. On the other hand, recall bias (cryotherapy is of-
ten applied by practice assistants and out of sight
from GPs) and social desirability bias (overestimation
of influence by evidence and underestimation of finan-
cial motives) could have played a role. However, GPs
practice cannot be evaluated in a more careful way
then we did.
Evidence versus practice
Ideally, treatment practice reflects available evidence on
effectiveness. According to the recent Cochrane review
on topical treatments for warts, evidence favours the
use of salicylic acid.7 In contrast, our survey shows that
GPs prefer cryotherapy over salicylic acid. The recent
National Health Service (NHS). Health Technology As-
sessment’s qualitative study on opinions with regard to
the treatment of warts shows a similar trend as our sur-
vey: health professionals’ opinions towards cryotherapy
were quite positive and opinions towards salicylic acid
were fairly negative.15 This discrepancy between evi-
dence and practice can be explained in different ways.
Firstly and most importantly, recommendations on the
treatment of warts favouring salicylic acid8,9 do not have
a firm evidence base since they are based on small low-
quality studies. Direct comparison between cryotherapy
and salicylic acid in the two available randomized stud-
ies did not show a difference in effectiveness.16,17 In ab-
sence of clear and direct evidence, GPs’ confidence in
the effectiveness of cryotherapy could represent the ac-
tual competence of cryotherapy. As a consequence, we
conclude in accordance with the Cochrane review that
more randomized trials are needed.7 Secondly, increas-
ing availability of liquid nitrogen could have led to in-
creasing demand for cryotherapy among patients.6 GPs
tend to act upon patient’s personal ideas and treatment
preferences when the natural history of the disease is fa-
vourable. Although GPs prefer an expectant awaiting
policy when the inconvenience caused by warts is lim-
ited (as shown in our study), they may comply with the
patient’s demand for cryotherapy nonetheless. Lastly, it
has been suggested that GPs prefer cryotherapy because
they financially profit from its implementation.18 In our
survey, however, only 5% of GPs report that financial
reasons influence their treatment choice.
Implications for future research
This survey clearly shows the discrepancy regarding
the treatment of warts between available evidence
and current practice. This may partly be due to the
low quality of the underlying evidence, which is a -
common phenomenon in minor ailments.19 Although
non-adherence to guidelines based on low-quality evi-
dence is of limited clinical importance for practice, it
is of high importance for clinical research. Only prag-
matic high-quality trials in primary care can solve this
problem.
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